{"schema":"sb.node.v1","id":"sb:e/904261b734238c4a6682c06a","kind":"entity","label":{"text":"myer","locale":"en"},"identity":{"anchor":"label:en:myer","strength":"label"},"asOf":{"knowledgeCutoff":"2026-10-29T23:27:11.436223+00:00","releaseId":"sb-5278fe97455c","snapshot":"deploy 4eb44af96aa019751c00666e75064bc109388622"},"lens":{"kind":"public"},"build":{"plane":"projected","builtFrom":["entity_graph.slim.json","entity_receipts (deploy asset)","event_graph.json","truth_records (deploy asset)","corroborated_record.json"],"rule":"node-projection.entity@v1"},"standing":{"evidence":{"supporting":322,"separatePublishers":141,"basis":"documents that mention the subject and the outlets that carried them; a mention is evidence the referent is in use, not evidence about any claim","receiptsOnTopic":{"state":"partial","share":0.22,"named":71,"of":322,"basis":"documents whose own title or summary lead names the subject, over every counted document that mentions it anywhere (the entity graph's measurement); receipts are drawn only from rows whose own title or URL names the subject (the entity graph's subject gate)","blind":["only 22% of the 322 documents measured name the subject in their own text; the rest mention it in passing, so standing.evidence.supporting overstates coverage about it"]}},"admission":{"state":"canonical","kind":"receipted","kindBasis":"receipt-on-file","reason":"entity graph provenance 'curated'; promoted from the corpus by the machine rule; the promotion receipt (bars, evidence, snapshot) is on file but its contents are not yet served","policy":"promotion (receipt on file; contents not yet served)","admittedOn":"2026-10-28"},"disposition":{"state":"served","reason":"public record"},"validity":{"from":"2026-04-24","to":"2026-10-29","basis":"first and last day we saw it mentioned; not the subject's own lifetime"},"measurement":{"state":"partial","blind":["assertion coverage 0.012: about 99% of mentions carry no typed assertion"]}},"dimensions":{"domains":["biotech_pharma"],"activeDays":58,"assertions":{}},"up":[],"upNote":"An entity is a root: it is contained by nothing. Pan out by following R.","children":{"count":10,"byKind":{"observation":10},"withheld":{"state":"withheld","count":2,"reason":"2 receipts withheld: no source link (the same rule the topic record applies)"},"items":[{"id":"sb:o/29d0d93f8df5d4cb15db9a75","kind":"observation","label":"Oklahoma Farm Report · 2026-10-28 · Retiring Address of National FFA President Trey Myers at 99th National FFA Convention","url":"https://www.oklahomafarmreport.com/2026/10/28/retiring-address-of-national-ffa-president-trey-myers-at-99th-national-ffa-convention/?utm_source=rss&utm_medium=rss&utm_campaign=retiring-address-of-national-ffa-president-trey-myers-at-99th-national-ffa-convention","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/2f8782b883276fbf760857b3","kind":"observation","label":"Bioxconomy · 2026-10-27 · Bristol Myers Squibb confirms patient death in multiple sclerosis CAR T trial","url":"https://www.bioxconomy.com/modalities/bristol-myers-squibb-confirms-patient-death-in-multiple-sclerosis-car-t-trial","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/2390645403bb768a51a4df24","kind":"observation","label":"Bioxconomy · 2026-10-26 · Bristol Myers Squibb leads $237m Series E for AI drug developer Pathos AI","url":"https://www.bioxconomy.com/investment/bristol-myers-squibb-leads-237m-series-e-for-ai-drug-developer-pathos-ai","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/18c748ea55b38f2ab8e6812e","kind":"observation","label":"Endpoints News · 2026-10-25 · #ESMO26: Pfizer looks beyond lung cancer flop as BioNTech, Bristol Myers show early activity","url":"https://endpoints.news/esmo26-pfizer-says-failed-adc-from-seagen-buy-shows-promise-in-post-hoc-review/","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/33b1aac72e9bdc30f296df34","kind":"observation","label":"STAT News · 2026-10-23 · STAT+: Patient dies in Bristol Myers Squibb autoimmune CAR-T trial","url":"https://www.statnews.com/2026/10/23/bristol-myers-squibb-car-t-therapy-autoimmune-trial-death/?utm_campaign=rss","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/352cc5fa0090270edd453670","kind":"observation","label":"Endpoints News · 2026-10-23 · Pathos raises $237M at $3B valuation, signs Bristol Myers neuro partnership","url":"https://endpoints.news/pathos-raises-237m-at-3b-valuation-signs-bristol-myers-neuro-partnership/","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/0d56654adbd6b73900e3ef30","kind":"observation","label":"Oklahoma Farm Report · 2026-10-20 · Trey Myers Reflects on FFA Leadership, Agricultural Roots as National President","url":"https://www.oklahomafarmreport.com/2026/10/20/trey-myers-reflects-on-ffa-leadership-agricultural-roots-as-national-president/?utm_source=rss&utm_medium=rss&utm_campaign=trey-myers-reflects-on-ffa-leadership-agricultural-roots-as-national-president","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/2bb931a8a872013b0e1ddd10","kind":"observation","label":"24/7 Wall St. · 2026-10-16 · Bristol Myers Squibb’s 4.2% Dividend Yield Comes With a Trade-Off Investors Should Know","url":"https://247wallst.com/investing/2026/10/16/bristol-myers-squibbs-4-2-dividend-yield-comes-with-a-trade-off-investors-should-know/","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/06c16326fef891722cd9784e","kind":"observation","label":"Citybiz · 2026-10-14 · Carr, Riggs & Ingram Merges with Stroemer & Company, Expands into Fort Myers and Pembroke Pines","url":"https://www.citybiz.co/article/918161/carr-riggs-ingram-merges-with-stroemer-company-expands-into-fort-myers-and-pembroke-pines/","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/6119e844403364f2f5c35c38","kind":"observation","label":"TechCrunch · 2026-10-11 · Dawn Myers is making it easier to style, detangle, and care for curly hair","url":"https://techcrunch.com/2026/10/11/dawn-myers-is-making-it-easier-to-style-detangle-and-care-for-curly-hair/","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}}],"cursor":null,"order":"newest first; we keep the 10 newest receipts for this entity whose own title or URL (the entity graph's subject gate) names it; each says which in match. Its other observations are counted in standing.evidence.supporting but are not addressable in v1"},"relations":{"count":11,"byKind":{"claim":1,"co-mentioned":10},"items":[{"id":"sb:p/ed1a1cffcdfacf85aad998ae","kind":"claim","label":"Bristol Myers Squibb confirms patient death in multiple sclerosis CAR T trial — reported by two","role":"named-in","relationKind":"claim","members":1},{"kind":"relation","label":"co-mentioned with bristol myers squibb (114 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/1629ca5ad1205863d727b8be"},{"kind":"relation","label":"co-mentioned with ai (65 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/412dec1698570a8603e984bc"},{"kind":"relation","label":"co-mentioned with fda (51 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/a6bd4f72f5f7971a3bf3cd61"},{"kind":"relation","label":"co-mentioned with united states (46 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/1bc7e380e1812fada4f90630"},{"kind":"relation","label":"co-mentioned with texas (45 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/82971abe6884aaa8bcb55801"},{"kind":"relation","label":"co-mentioned with trump (42 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/0aaffc63cda7c4e51135d39f"},{"kind":"relation","label":"co-mentioned with united kingdom (42 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/c29786594581ce90c487fa05"},{"kind":"relation","label":"co-mentioned with florida (39 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/3fc57cc9d7cd59979d8dfb8e"},{"kind":"relation","label":"co-mentioned with pfizer (32 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/8925ffc0ed461e799639586f"}],"cursor":"c1.eyJpZCI6InNiOmUvOTA0MjYxYjczNDIzOGM0YTY2ODJjMDZhIiwibCI6InJlbGF0aW9ucyIsIm8iOjEwLCJrIjpudWxsLCJhIjoiMjAyNi0xMC0yOVQyMzoyNzoxMS40MzYyMjMrMDA6MDAifQ","order":"situations first, then claims (the subject's own maintained record, then site-wide corroborated clusters; each label ends with its standing), then co-mentions by shared documents, descending. Co-mentions are the ten strongest the entity graph keeps per entity"},"edge":{"state":"continues"},"links":{"rest":"/api/v1/node/e/904261b734238c4a6682c06a","mcp":"traverse {\"id\":\"sb:e/904261b734238c4a6682c06a\"}","page":"/entity/myer/"},"limits":{"levelsPerCall":1,"pageSize":10,"maxPageSize":50,"membersMax":50,"statement":"One level per call: depth is 1 and only 1, and there is no whole-graph dump. pageSize 1-50 (default 10); a page limit is a cursor, never an edge. Members are listed up to 50. At most 60 traverse calls a minute per caller (runaway-loop protection, not a meter). One knowledge cutoff is served: the deploy's."},"actions":[{"verb":"unfold","lit":true,"effect":"read","layer":"free-record","call":"traverse {\"id\":\"sb:e/904261b734238c4a6682c06a\",\"level\":\"children\"}"},{"verb":"fold","lit":true,"effect":"read","layer":"free-record","call":"traverse {\"id\":\"sb:e/904261b734238c4a6682c06a\"}"},{"verb":"panOut","lit":false,"effect":"read","layer":"free-record","reason":"An entity is a root: it is contained by nothing. Pan out by following R."},{"verb":"follow","lit":true,"effect":"read","layer":"free-record","call":"traverse {\"id\":\"sb:e/904261b734238c4a6682c06a\",\"level\":\"relations\"}"},{"verb":"receipts","lit":false,"effect":"read","layer":"free-record","reason":"receipts are the observations below this node; unfold to reach them"},{"verb":"edge","lit":true,"effect":"read","layer":"free-record","call":"traverse {\"id\":\"sb:e/904261b734238c4a6682c06a\"}"},{"verb":"asOf","lit":false,"effect":"read","layer":"free-record","reason":"v1 serves one knowledge cutoff, this deploy's; walking an earlier cutoff needs retained history, which v1 does not keep"},{"verb":"switchObserver","lit":false,"effect":"read","layer":"free-record","reason":"the public record is the same for every observer; traversal through a Watch's lens is not served in v1"},{"verb":"readOriginal","lit":false,"effect":"read","layer":"free-record","reason":"no translation is applied on this node; every label is the source's own text"},{"verb":"save","lit":false,"effect":"watch-declaration","layer":"watch","reason":"saving applies to a configured Watch; configure one around this node first (free), then save it"},{"verb":"deliver","lit":false,"effect":"watch-declaration","layer":"watch","reason":"delivery applies to a saved Watch"},{"verb":"format","lit":false,"effect":"watch-declaration","layer":"watch","reason":"output format applies to a saved Watch"},{"verb":"deltaR","lit":false,"effect":"read","layer":"watch","reason":"Delta R needs a saved Watch with a previous reading"},{"verb":"read","lit":false,"effect":"read","layer":"one-time-read","reason":"one-time Reads are not offered through this door; use ask"}]}